180 related articles for article (PubMed ID: 10879662)
1. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
Lama G; Luongo I; Piscitelli A; Salsano ME
Clin Nephrol; 2000 Jun; 53(6):432-6. PubMed ID: 10879662
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
Prasher PK; Varma PP; Baliga KV
J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
[TBL] [Abstract][Full Text] [Related]
3. [Reduction of proteinuria by enalapril, in children with nephrotic syndrome resistant to prednisone].
Pérez-Cortés G; Santos-Atherton D; López-Montaño E
Gac Med Mex; 1988; 124(9-10):371-4. PubMed ID: 2854521
[No Abstract] [Full Text] [Related]
4. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Kumar NS; Singh AK; Mishra RN; Prakash J
J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
[TBL] [Abstract][Full Text] [Related]
5. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
Bianchini G; Letizia C; Domenici A; Scavo D
Drugs Exp Clin Res; 1991; 17(5):263-9. PubMed ID: 1661665
[TBL] [Abstract][Full Text] [Related]
6. Enalapril and prednisone in children with nephrotic-range proteinuria.
Delucchi A; Cano F; Rodriguez E; Wolff E; Gonzalez X; Cumsille MA
Pediatr Nephrol; 2000 Oct; 14(12):1088-91. PubMed ID: 11045392
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
Proesmans W; Wambeke IV; Dyck MV
Pediatr Nephrol; 1996 Oct; 10(5):587-9. PubMed ID: 8897561
[TBL] [Abstract][Full Text] [Related]
8. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
Proesmans W; Van Dyck M; Devriendt K
Nephrol Dial Transplant; 2009 Apr; 24(4):1335-8. PubMed ID: 19147669
[TBL] [Abstract][Full Text] [Related]
9. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
Nakhoul F; Khankin E; Yaccob A; Kawachi H; Karram T; Awaad H; Nakhoul N; Hoffman A; Abassi Z
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
11. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
[TBL] [Abstract][Full Text] [Related]
12. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[TBL] [Abstract][Full Text] [Related]
13. Enalapril dosage in steroid-resistant nephrotic syndrome.
Bagga A; Mudigoudar BD; Hari P; Vasudev V
Pediatr Nephrol; 2004 Jan; 19(1):45-50. PubMed ID: 14648339
[TBL] [Abstract][Full Text] [Related]
14. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
15. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A
Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802
[TBL] [Abstract][Full Text] [Related]
17. Enalapril treatment of proteinuria in normotensive children.
Sasinka MA; Podracka L; Boor A; Jurkovic I; Mitro A; Kovacs L
Bratisl Lek Listy; 1999 Sep; 100(9):476-80. PubMed ID: 10645036
[TBL] [Abstract][Full Text] [Related]
18. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
19. Enalapril prevents fatty liver in nephrotic rats.
Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
J Nephrol; 2002; 15(4):358-67. PubMed ID: 12243364
[TBL] [Abstract][Full Text] [Related]
20. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
Supavekin S; Surapaitoolkorn W; Tancharoen W; Pattaragarn A; Sumboonnanonda A
Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
